FindTrial
Sign In

To Study Effectiveness of Haritakyadi Kwath In Madhumeha.

Clinical Study To Evaluate Efficacy Of Haritakyadi Kwath In Madhumeha With Special Reference To Type II Diabetes Mellitus.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023137
Enrollment
130
Registered
2020-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Haritakyadi Kwath: Route of Administration: Oral Dosage:40 ml Twice a Day before food with honey. Duration of Treatment:28 Days. Control Intervention1: Tab.Metformin: Route of Administr

Sponsors

Hon Shri Annasaheb Dange Ayurvedic Medical College Ashta Sangli
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Willing to give consent to participate in the study. 2.Type of Disease-Apathyanimittaja Prameha (Diabetes Mellitus type2 NIDDM). 3.Fasting Blood sugar range- 126 to 250 mg/dl. 4.Post Prandial Blood sugar range-200 to 325 mg/dl

Exclusion criteria

Exclusion criteria: 1.Patient not willing to participate in the study or not in position to give consent. 2.Patients of IDDM (Insulin Dependent Diabetes Mellitus)(DM Type 1). 3.Patients below 25 years of age & above 70 years of age. 4.Patients with Blood Sugar Level â?? FBS > 250 mg/dl PPBS > 325 mg/dl. 5.Patients with Gestational Diabetes. 6.Patients with severe complications (Chronic)[Micro & Macro-Vascular complications] 7.Patients in whom DM is caused due to Endocrinopathies like: - a) Acromegaly b) Cushingâ??s Syndrome c)Glucagonoma d)Pheochromocytoma e)Hyperthyroidism. 8. Patients in whom DM is caused as a drug induced complications . Ex:- a) Steroids b) Thiazide like Diuretics c) Nicotinic Acid d) Protease Inhibitors e) Beta Blockers 9.Patients suffering from any serious systemic disorders. 10.Patients with DKA (Diabetic Ketoacidosis), Lactic acidosis

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of Haritakyadi Kwath in Madhumeha.Timepoint: Total Duration of treatment : 28Days. Follow up Assessment of trial drug during the course of treatment will be done on 0th- 7th-14th-21st -28th day of treatment. And after completion of treatment.—

Secondary

MeasureTime frame
To compare the efficacy of Haritakyadi Kwath with MetforminTimepoint: Total Duration of treatment : 28Days. Follow up Assessment of trial drug during the course of treatment will be done on 0th- 7th-14th-21st -28th day of treatment. And after completion of treatment.—

Countries

India

Contacts

Public ContactDr Smita Lokhande

Maharashtra University Of Health Sciences, Nashik

yoshitpriya@gmail.com8149556591

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026